Retroperitoneal haematoma associated with low molecular weight heparin

Anaesthesia and Intensive Care

Volumn 30, Issue 5, 2002, Pages 665-667

  Power, G E ^a   Rogers, P ^a  

^a Queensland Government   (Australia)

Author keywords

Anticoagulant: Enoxaparin; Complications: Haematoma, retroperitoneal

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ATORVASTATIN; DIGOXIN; DILTIAZEM; DOPAMINE; ENOXAPARIN; FUROSEMIDE; INDOMETACIN; INFUSION FLUID; IRBESARTAN; LOW MOLECULAR WEIGHT HEPARIN; PREDNISONE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INOTROPISM; ISCHEMIC HEART DISEASE; MALE; RESUSCITATION; RETROPERITONEAL HEMATOMA; THROMBOEMBOLISM; TREATMENT FAILURE;

EID: 0036798542     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0203000520     Document Type: Article

References (11)

1. Aguilar D, Goldhaber SZ. Clinical uses of low-molecular-weight heparins. Chest 1999; 115:1418-1423.
2. Levine MN, Hirsh J. Hemorrhagic complications of anticoagulant therapy. Semin Thromb Hemost 1986; 12:39-57.
3. Vandermeulen EP. Van Aken H, Vermylen J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg 1994; 79:1165-1177.
4. Bergqvist D, Lindblad B, Matzsch T. Low molecular weight heparin for thromboprophylaxis and epidural/spinal anaesthesia-is there a risk? Acta Anaesthesiol Scand 1992; 36:605-609.
5. Montoya JP, Pokala N, Melde SL. Retroperitoneal hematoma and enoxaparin. Ann Intern Med 1999; 131:796-797.
6. Antonelli D, Fares A, Anene C. Enoxaparin associated with huge abdominal wall hematomas: a report of two cases. Am Surg 2000; 66:797-800.
7. Lumpkin MM. FDA public health advisory. Anesthesiology 1998; 88:27A-28A.
8. Houde JP, Steinberg G. Intrahepatic hemorrhage after use of low-molecular-weight heparin for total hip arthroplasty. J Arthroplasty 1999; 14:372-374.
9. Klein SM, D'Ercole F, Greengrass RA, Warner DS. Enoxaparin associated with psoas hematoma and lumbar plexopathy after lumbar plexus block. Anesthesiology 1997; 87:1576-1579.
10. Brophy DF, Wazny LD, Gehr TW, Comstock TJ, Venitz J. The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease. Pharmacotherapy 2001; 21:169-174.
11. Gerlach AT, Pickworth KK, Seth SK, Tanna SB, Barnes JF. Enoxaparin and bleeding complications: a review of patients with and without renal insufficiency. Pharmacotherapy 2000; 20:771-775.